The FDA Just Revoked Its Emergency Authorization of Hydroxychloroquine

“Unlikely to produce an antiviral effect.”

Doug Mills/CNP/Zuma

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

Another update in the hydroxychloroquine saga: The Food and Drug Administration has revoked its emergency use authorization for the controversial drug, which President Donald Trump has aggressively promoted and, at one point, claimed to be taking prophylactically.

The FDA said in its announcement that the suggested doses of chloroquine and hydroxychlorine “are unlikely to produce an antiviral effect” and that data from a recent randomized controlled trial did not show benefits over standard of care alone.

The bottom line, according to the FDA, is that “it is no longer reasonable to believe that oral formulations of HCQ and CQ may be effective in treating COVID-19, nor is it reasonable to believe that the known and potential benefits of these products outweigh their known and potential risks.”

Trump said in late May that he’d finished his two-week regimen of hydroxychloroquine—perhaps now he’ll stop urging others to take the drug.

FACT:

Mother Jones was founded as a nonprofit in 1976 because we knew corporations and the wealthy wouldn't fund the type of hard-hitting journalism we set out to do.

Today, reader support makes up about two-thirds of our budget, allows us to dig deep on stories that matter, and lets us keep our reporting free for everyone. If you value what you get from Mother Jones, please join us with a tax-deductible donation today so we can keep on doing the type of journalism 2020 demands.

payment methods

FACT:

Mother Jones was founded as a nonprofit in 1976 because we knew corporations and the wealthy wouldn't fund the type of hard-hitting journalism we set out to do.

Today, reader support makes up about two-thirds of our budget, allows us to dig deep on stories that matter, and lets us keep our reporting free for everyone. If you value what you get from Mother Jones, please join us with a tax-deductible donation today so we can keep on doing the type of journalism 2020 demands.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate